PPP

PYC THERAPEUTICS LIMITED

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪466.61 M‬AUD
−0.006AUD
‪−22.79 M‬AUD
‪1.54 B‬
Beta (1Y)
−0.78

About PYC THERAPEUTICS LIMITED

CEO
Rohan Hockings
Headquarters
Nedlands
Website
Founded
2001
ISIN
AU000000PYC7
FIGI
BBG000BWKBQ1
PYC Therapeutics Ltd. is a drug-development company, which provides a new generation of RNA therapeutics to meet unmet need in disease. It develops intracellular biological therapeutics including its own preclinical oncology payloads, using its proprietary cell Functional Penetrating Phylomers. The company was founded by Richmond Miles Hopkins and Paul Michael Watt on October 9, 2001, and is headquartered in Nedlands, Australia.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of PYC is 0.100 AUD — it has increased by 3.09% in the past 24 hours. Watch PYC THERAPEUTICS LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange PYC THERAPEUTICS LIMITED stocks are traded under the ticker PYC.
PYC stock hasn't changed in a week, the month change is a 6.38% rise, over the last year PYC THERAPEUTICS LIMITED has showed a 81.82% increase.
We've gathered analysts' opinions on PYC THERAPEUTICS LIMITED future price: according to them, PYC price has a max estimate of 0.37 AUD and a min estimate of 0.34 AUD. Watch PYC chart and read a more detailed PYC THERAPEUTICS LIMITED stock forecast: see what analysts think of PYC THERAPEUTICS LIMITED and suggest that you do with its stocks.
PYC reached its all-time high on May 26, 2006 with the price of 0.667 AUD, and its all-time low was 0.008 AUD and was reached on May 16, 2014. View more price dynamics on PYC chart.
See other stocks reaching their highest and lowest prices.
PYC stock is 8.08% volatile and has beta coefficient of −0.78. Track PYC THERAPEUTICS LIMITED stock price on the chart and check out the list of the most volatile stocks — is PYC THERAPEUTICS LIMITED there?
Today PYC THERAPEUTICS LIMITED has the market capitalization of ‪466.61 M‬, it has increased by 14.13% over the last week.
Yes, you can track PYC THERAPEUTICS LIMITED financials in yearly and quarterly reports right on TradingView.
PYC THERAPEUTICS LIMITED is going to release the next earnings report on Aug 27, 2024. Keep track of upcoming events with our Earnings Calendar.
PYC THERAPEUTICS LIMITED revenue for the last quarter amounts to ‪9.12 M‬ AUD despite the estimated figure of 0 AUD. In the next quarter revenue is expected to reach 0 AUD.
PYC net income for the last quarter is ‪−15.09 M‬ AUD, while the quarter before that showed ‪−6.55 M‬ AUD of net income which accounts for −130.44% change. Track more PYC THERAPEUTICS LIMITED financial stats to get the full picture.
No, PYC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PYC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PYC THERAPEUTICS LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PYC THERAPEUTICS LIMITED technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PYC THERAPEUTICS LIMITED stock shows the buy signal. See more of PYC THERAPEUTICS LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.